Status:
COMPLETED
A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST)
Lead Sponsor:
University College London Hospitals
Collaborating Sponsors:
North Middlesex University Hospital
Barnet and Chase Farm Hospitals NHS Trust
Conditions:
Bronchogenic Carcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
In the UK, staging of lung cancer is time consuming (taking on average more than 3 weeks), costly and inaccurate in up to 20% of cases. The investigators wish to determine whether using the newer tech...
Eligibility Criteria
Inclusion
- Consecutive patients suspected of lung cancer on CT scan
- Written informed consent
- Able to tolerate bronchoscopy and thoracic surgery
Exclusion
- Evidence of severe or uncontrolled systemic disease that makes it undesirable for the patient to participate in the trial
- Any disorder making reliable informed consent impossible
- Patients with extra-thoracic disease, supraclavicular lymphadenopathy or pleural effusion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT00652769
Start Date
March 1 2008
End Date
July 1 2012
Last Update
November 1 2017
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Barnet General Hospital
London, United Kingdom, EN5 3DJ
2
North Middlesex University Hospital
London, United Kingdom, N18 1QX
3
Whittington Hospital NHS Trust
London, United Kingdom, N19 5NF
4
University College London Hospital NHS Trust
London, United Kingdom, WC1E 6AU